Showing results (51-60 of 179) with videos related to
Sort By:
Pageof 18
European Journal of Medicinal Chemistry|October 27, 2011
Pharmacophore identification, virtual screening and biological evaluation of prenylated flavonoids derivatives as PKB/Akt1 inhibitorsXiaowu Dong, Xinglu Zhou, Hui Jing, et al.Frontiers in Endocrinology|June 23, 2025
The association between pancreatic diseases and pancreatic fat content: a cross-sectional study from the UK BiobankJing Gao, Xiaowu Dong, Xiaolei Shi, et al.European Journal of Medicinal Chemistry|February 11, 2014
Integrating docking scores, interaction profiles and molecular descriptors to improve the accuracy of molecular docking: toward the discovery of novel Akt1 inhibitorsWenhu Zhan, Daqiang Li, Jinxin Che, et al.Journal of Computer-Aided Molecular Design|June 5, 2026
Discovery of potent and selective LRRK2 inhibitors with preserved activity against the G2019S mutant via multi-stage virtual screeningYan Ma, Xinle Yang, Wentao Wang, et al.Royal Society Open Science|August 16, 2018
Ligand-based pharmacophore model for the discovery of novel CXCR2 antagonists as anti-cancer metastatic agentsJinxin Che, Zhilong Wang, Haichao Sheng, et al.Archiv Der Pharmazie|February 13, 2009
Synthesis and in-vitro antitumor activities of some mannich bases of 9-alkyl-1,2,3,4-tetrahydrocarbazole-1-onesJing Chen, Jianshu Lou, Tao Liu, et al.Plos One|August 21, 2012
Identification of novel piperazinylquinoxaline derivatives as potent phosphoinositide 3-kinase (PI3K) inhibitorsPeng Wu, Yi Su, Xianghong Guan, et al.ACS Medicinal Chemistry Letters|July 16, 2025
Discovery of Novel c‑MET Inhibitors for Hepatocellular Carcinoma Using an Integrated Virtual Screening ApproachRushan Fei, Na Lin, Xin Zhang, et al.Beilstein Journal of Organic Chemistry|May 13, 2026
Advantages of PROTACs in achieving selective degradation of homologous protein familiesLuxi Yang, Xinfei Mao, Jingyi Zhang, et al.European Journal of Medicinal Chemistry|March 22, 2026
The double-edged sword of pyroptosis targeting in cancer therapyShihui Mao, Tao Lei, Fangrong Shi, et al.Pageof 18